의료용품 › 의약품
기타
HS 300490중국 → 대만
1개요
- 도착국 관세: 0% (제1란, 30049010107) — 중국과의 특혜협정이 없어 기본/MFN 세율이 적용됩니다.
- 영업세(營業稅): 5%
- 이 코드는: 기타
- 주의할 제도: 대만 특송 소액면세 및 반복 통관 제한NT$2,000 이하 특송 화물은 면세이나, 동일 수하인이 반년에 6회를 초과하면 면세 배제·정식 신고로 전환됨.web.customs.gov.tw
핵심 포인트
- 소액면세: 동일 선적 완세가격 NT$2,000 이하는 관세·영업세·화물세 면제. 같은 납세의무자가 반년도 내 6회를 초과하면 빈번수입자로 분류되어 면세가 중단됩니다.
- 영업세 5%를 세관이 대징하며, 추광무역서비스비 0.04%, 법정 품목의 화물세, 연주세가 함께 부과될 수 있습니다.
- 보관업자 위임은 의무가 아닙니다. 납세의무자가 직접 신고할 수 있으나, 신고는 단일창구를 통한 전자신고여야 합니다.
- 특송화물은 완세가격에 따라 X1(서류), X2(NT$2,000 이하 면세), X3(NT$2,001~50,000 과세), X4(NT$50,000 초과, 일반 진구보단 필요)로 구분됩니다.
- 중국 본토에서 수입하기 전에는 품목분류표 「수입규정」 란의 MW0·MP1 여부를 반드시 확인해야 합니다.
기준일: 2026-07-29
2품목분류
HS6 품명
- ko기타
- enOther anesthetics
- zh_hant其他麻醉劑
- zh_hans其他麻醉剂
대만 세번
| 세번 | 품명 |
|---|---|
| 30049010107 | 醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類)Medicaments,containing thiamylal,5-allyl-5-(1-methylbutyl)-2-thiobarbiturates, including: Isomers, Esters, Ethers, Salts |
| 30049010205 | 醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Ketamine , and its isomer, esters, ethers, salts |
| 30049010303 | 醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者Medicaments, containing Propofol , Etomidate, and their isomer, esters, ethers, salts |
| 30049010900 | 其他麻醉劑Other anesthetics |
| 30049020007 | 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparations of gennetic recombinants |
| 30049030005 | 營養與電解質液Nutrients and electrolytes |
| 30049040003 | 洗腎用清洗液,具有劑量或零售包裝式樣者Hemodialysis concentrate, put up in measured doses or in forms or packings for retail sale |
| 30049050000 | 磺胺藥Antibacterial, sulfa drugs |
| 30049061007 | 中藥酒劑Chinese medicine wine |
| 30049069009 | 其他中藥製劑Other chinese medicine preparations |
| 30049071005 | 抗癌藥Anti-cancer preparations |
| 30049072004 | 抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections |
| 30049080004 | 農藥中毒解毒劑Pesticide-poisoning cures |
| 30049091001 | 抗排斥醫藥製劑Immunosuppressive preparations |
| 30049092000 | 安瓿裝蒸餾水Water, distilled, in ampoules |
| 30049099101 | 抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine |
| 30049099218 | 醫藥製劑,含有西可巴比妥者Medicaments, containing secobarbital |
| 30049099227 | 醫藥製劑,含有異戊巴比妥者Medicaments, containing amobarbital |
| 30049099316 | 醫藥製劑,含有三唑他(三唑侖)者Medicaments, containing Triazolam |
| 30049099325 | 醫藥製劑,含有氟硝西泮者Medicaments, containing Flunitrazepam |
| 30049099334 | 醫藥製劑,含有氯甲西泮(甲基樂耐平)者Medicaments, containing Lormetazepam |
| 30049099343 | 醫藥製劑,含有氟地西泮(氟二氮平)者Medicaments, containing Fludiazepam |
| 30049099352 | 醫藥製劑,含有舒樂安定(伊疊唑侖)者Medicaments, containing Estazolam |
| 30049099361 | 醫藥製劑,含有阿普唑他(三氮二氮平)者Medicaments, containing Alprazolam |
| 30049099370 | 醫藥製劑,含有替馬西泮(甲羥氮平)者Medicaments, containing Temazepam |
| 30049099389 | 醫藥製劑,含有咪達唑他(咪氟唑侖)者Medicaments, containing Midazolam |
| 30049099414 | 醫藥製劑,含有特拉嗎竇者Medicaments, containing Tramadol |
| 30049099423 | 醫藥製劑,含有伯替唑他者Medicaments, containing Brotizolam |
| 30049099432 | 醫藥製劑,含有唑匹可隆者Medicaments, containing Zopiclone |
| 30049099441 | 玻璃體替代物Viscoelastic material for ophthalmic surgery |
| 30049099450 | 醫藥製劑,含有札來普隆者Medicaments, containing Zaleplon |
| 30049099469 | 醫藥製劑,含有佐沛眠者Medicaments, containing Zolpidem |
| 30049099520 | 醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Remifentanil, and its isomer, esters, ethers, salts |
| 30049099539 | 醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Alfentanyl , and its isomer, esters, ethers, salts |
| 30049099548 | 醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Fentanyl , and its isomer, esters, ethers, salts |
| 30049099557 | 醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者Medicaments, containing Methadone , and its isomer, esters, ethers, salts |
| 30049099566 | 醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentazocine , and its isomer, esters, ethers, salts |
| 30049099575 | 醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Sufentanil , and its isomer, esters, ethers, salts |
| 30049099584 | 醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者Medicaments, containing Tetrahydrocannabinols, and its isomer, esters, ethers, salts |
| 30049099593 | 醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者Medicaments, containing Methylphenidate , and its isomer, esters, ethers, salts |
| 30049099619 | 醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者Medicaments, containing Tapentadol, and its isomers, esters, ethers, salts |
| 30049099628 | 醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentobarbital(excluding amobarbital), and its isomer, esters, ethers, salts |
| 30049099637 | 醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nimetazepam , and its isomer, esters, ethers, salts |
| 30049099646 | 醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者Medicaments, containing Barbital , and its isomer, esters, ethers, salts |
| 30049099655 | 醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Bromazepam , and its isomer, esters, ethers, salts |
| 30049099664 | 醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Lorazepam , and its isomer, esters, ethers, salts |
| 30049099673 | 醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Medazepam , and its isomer, esters, ethers, salts |
| 30049099682 | 醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者Medicaments, containing Meprobamate , and its isomer, esters, ethers, salts |
| 30049099691 | 醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nitrazepam , and its isomer, esters, ethers, salts |
| 30049099717 | 醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nordazepam , and its isomer, esters, ethers, salts |
| 30049099726 | 醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazepam , and its isomer, esters, ethers, salts |
| 30049099735 | 醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazolam , and its isomer, esters, ethers, salts |
| 30049099744 | 醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pemoline , and its isomer, esters, ethers, salts |
| 30049099753 | 醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing clobazam , and its isomer, esters, ethers, salts |
| 30049099762 | 醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clonazepam , and its isomer, esters, ethers, salts |
| 30049099771 | 醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clorazepate , and its isomer, esters, ethers, salts |
| 30049099780 | 醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Cloxazolam , and its isomer, esters, ethers, salts |
| 30049099799 | 醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Diazepam , and its isomer, esters, ethers, salts |
| 30049099815 | 醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者Medicaments, containing Flurazepam , and its isomer, esters, ethers, salts |
| 30049099824 | 醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Prazepam , and its isomer, esters, ethers, salts |
| 30049099833 | 醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者Medicaments, containing Modafinil , and its isomer, esters, ethers, salts |
| 30049099842 | 醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者Medicaments, containing Butorphanol , and its isomer, esters, ethers, salts |
| 30049099851 | 醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者Medicaments, containing Clobenzorex , and its isomer, esters, ethers, salts |
| 30049099860 | 醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Lisdexamphetamine , and its isomer, esters, ethers, salts |
| 30049099904 | 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale |
중국 수출 신고용 세번(참고)
- 30049010---含有磺胺类
- 30049020---含有联苯双酯
- 30049051----中药酒
- 30049052----片仔癀
- 30049053----白药
- 30049054----清凉油
- 30049055----安宫牛黄丸
- 30049059----其他
- 30049090---其他
대만 결정례 상위 3건
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)
- 其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)
기준일: 2026-07-29
3관세·세금
중국과의 특혜협정이 없어 기본/MFN 세율이 적용됩니다.
| 세번 | 품명 | 제1란 | 제2란 | 제3란 |
|---|---|---|---|---|
| 30049010107 | 醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類) | 0% | 0% | 0% |
| 30049010205 | 醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 0% |
| 30049010303 | 醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 0% |
| 30049010900 | 其他麻醉劑 | 0% | 0% | 0% |
| 30049020007 | 血液代用品與血漿代用品及基因重組製劑 | 0% | 0% | 0% |
| 30049030005 | 營養與電解質液 | 0% | 0% | 10% |
| 30049040003 | 洗腎用清洗液,具有劑量或零售包裝式樣者 | 0% | 0% | 10% |
| 30049050000 | 磺胺藥 | 0% | 0% | 20% |
| 30049061007 | 中藥酒劑 | 20% | 0% | 50% |
| 30049069009 | 其他中藥製劑 | 0% | 0% | 12.5% |
| 30049071005 | 抗癌藥 | 0% | 0% | 0% |
| 30049072004 | 抗人類免疫缺乏病毒感染用藥 | 0% | 0% | 10% |
| 30049080004 | 農藥中毒解毒劑 | 0% | 0% | 0% |
| 30049091001 | 抗排斥醫藥製劑 | 0% | 0% | 10% |
| 30049092000 | 安瓿裝蒸餾水 | 0% | 0% | 10% |
| 30049099101 | 抗過敏抗組織胺用藥 | 0% | 0% | 10% |
| 30049099218 | 醫藥製劑,含有西可巴比妥者 | 0% | 0% | 10% |
| 30049099227 | 醫藥製劑,含有異戊巴比妥者 | 0% | 0% | 10% |
| 30049099316 | 醫藥製劑,含有三唑他(三唑侖)者 | 0% | 0% | 10% |
| 30049099325 | 醫藥製劑,含有氟硝西泮者 | 0% | 0% | 10% |
| 30049099334 | 醫藥製劑,含有氯甲西泮(甲基樂耐平)者 | 0% | 0% | 10% |
| 30049099343 | 醫藥製劑,含有氟地西泮(氟二氮平)者 | 0% | 0% | 10% |
| 30049099352 | 醫藥製劑,含有舒樂安定(伊疊唑侖)者 | 0% | 0% | 10% |
| 30049099361 | 醫藥製劑,含有阿普唑他(三氮二氮平)者 | 0% | 0% | 10% |
| 30049099370 | 醫藥製劑,含有替馬西泮(甲羥氮平)者 | 0% | 0% | 10% |
| 30049099389 | 醫藥製劑,含有咪達唑他(咪氟唑侖)者 | 0% | 0% | 10% |
| 30049099414 | 醫藥製劑,含有特拉嗎竇者 | 0% | 0% | 10% |
| 30049099423 | 醫藥製劑,含有伯替唑他者 | 0% | 0% | 10% |
| 30049099432 | 醫藥製劑,含有唑匹可隆者 | 0% | 0% | 10% |
| 30049099441 | 玻璃體替代物 | 0% | 0% | 10% |
| 30049099450 | 醫藥製劑,含有札來普隆者 | 0% | 0% | 10% |
| 30049099469 | 醫藥製劑,含有佐沛眠者 | 0% | 0% | 10% |
| 30049099520 | 醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099539 | 醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099548 | 醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099557 | 醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099566 | 醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099575 | 醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099584 | 醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099593 | 醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099619 | 醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099628 | 醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099637 | 醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099646 | 醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099655 | 醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099664 | 醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099673 | 醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099682 | 醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099691 | 醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099717 | 醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099726 | 醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099735 | 醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099744 | 醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099753 | 醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099762 | 醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099771 | 醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099780 | 醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099799 | 醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099815 | 醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099824 | 醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099833 | 醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099842 | 醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099851 | 醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099860 | 醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099904 | 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者 | 0% | 0% | 10% |
- · 영업세 = (완세가격 + 수입세 + 화물세 또는 연주세 + 담배건강복지부담금) × 5%. 영업세법 제41조에 따라 세관이 대징합니다.
- · 추광무역서비스비(推廣貿易服務費): 완세가격의 0.04%(최저 부과 기준 있음).
- · 화물세(貨物稅): 화물세조례에 열거된 품목에만 부과됩니다. 전기기기, 차량, 유류·가스, 시멘트, 음료, 판유리, 고무타이어 등이며 과세표준은 완세가격 + 수입세입니다.
- · 연주세(菸酒稅): 궐련 1,000개비당 NT$1,590, 맥주 1리터당 NT$26, 증류주 1리터·1도당 NT$2.5 등. 담배에는 1,000개비당 NT$1,000의 건강복지부담금이 추가됩니다.
- · 특종화물및노무세(特種貨物及勞務稅): 일정 금액을 넘는 승용차·항공기·요트·고가품에 10%가 부과됩니다.
예상 세액 계산기
- 적용 관세율
- 0%
- 과세가격
- —
- 관세
- —
- 영업세(營業稅)
- —
- 총 예상 비용
- —
어림값입니다. 실제 세액은 과세가격 결정·품목분류·원산지 판정에 따라 달라집니다.
기준일: 2026-07-29
4요건·인증
- 503進口人用藥品(包括製劑、原料藥、助診藥類及人用生物製劑):應檢附(一)藥商許可執照影本及衛生福利部核發之(輸入)藥品許可證影本,或(二)衛生福利部核發之同意文件。
Importation of drugs (including pharmaceutical products, active pharmaceutical ingredients, diagnostics and biological products) for human use requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Ministry of Health and Welfa…
- 504一、進口人用醫療器材應依下列規定辦理:(一)應檢附衛生福利部核發之醫療器材許可證影本或同意文件,並應申報填列醫療器材許可證號碼(十四碼)。(二)如屬危險性醫療儀器,除應檢附衛生福利部核發之醫療器材許可證影本,及申報填列醫療器材許可證號碼(十四碼)外,並須檢附衛生福利部核准醫療機構購置之同意文件。二、非供人用者免依上述規定辦理。
1. Importation of medical devices for human use must be handled according to the following regulations: (1) A photocopy of the medical devices pre-marketing license or an approval document issued by the Ministry of Health and Welfare should be submitted. In addition, the number of the pre-marketing license (consisting of 14 letters and digits) must be declared and listed in the import declaration…
- 505進口中藥藥品(藥品許可證處方內容以中文標示者)應檢附(一)藥商許可執照影本及衛生福利部核發之(輸入)藥品許可證影本,或(二)衛生福利部中醫藥司核發之同意文件。
Importation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Department of Chinese Medicine and Pharmacy, Ministry…
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。
For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。
(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 814(一)進口人用中藥藥品,應依505規定辦理。(二)進口動物用中藥藥品,應依406規定辦理。(三)進口本項貨品未取得上開主管機關輸入許可文件者,不准進口。
(1) Importation of traditional chinese drugs for human use is governed by the regulation of "505". (2) Importation of veterinary chinese medicines is governed by the regulation of "406".(3) For importing good under this item without import approval document from the competent authority, is not allowed to be imported.
- MP1(一)大陸物品有條件准許輸入,應符合「大陸物品有條件准許輸入項目、輸入管理法規彙總表」之規定。(二)「大陸物品有條件准許輸入項目、輸入管理法規彙總表」內列有特別規定「MXX」代號者,應向國際貿易署辦理輸入許可證;未列有特別規定「MXX」代號者,依一般簽證規定辦理。
(1) Importation of Mainland China products in this category is conditionally permitted. The importation should conform to the regulations of "Consolidated List of Conditional Import Items of Mainland China Origin and Regulations Governing Import of Mainland China Origin Commodities".(2) Importation of items on the "Consolidated List of Conditional Import Items of Mainland China Origin and Regulat…
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
- MW0大陸物品不准輸入。
Importation of Mainland China products is prohibited.
관련 기관
- 재정부 관무서(關務署)수입통관, 세칙 분류, 관세 산정, 영업세·화물세 대징web.customs.gov.tw
- 관항무단일창구(單一窗口)수출입 보단 제출, 수입규정 조회, 세비 납부 전자 플랫폼portal.sw.nat.gov.tw
- 경제부 국제무역서물품 수출입 규정, 수입허가증, 대륙물품 수입관리(MW0·MP1)trade.gov.tw
- 경제부 표준검험국(BSMI)검사대상 상품의 보험·검증과 상품안전 표시bsmi.gov.tw
- 위생복리부 식품약물관리서(TFDA)수입식품 국경검사, 화장품 제품등록과 제품정보파일fda.gov.tw
- 농업부 동식물방역검역서동식물 및 그 제품의 수입검역aphia.gov.tw
기준일: 2026-08-27
5서류
중국 수출 서류
- 수출화물 보관단(出口貨物報關單)
- 발급:
- 발화인 또는 위임받은 보관기업이 단일창구로 신고
- 시점:
- 물품 적재 전
국경간 전자상거래 수출은 9610, 9710, 9810 등 전용 감관방식 코드를 사용합니다.
공식 안내 - 상업송장과 포장명세서
- 발급:
- 수출기업
- 시점:
- 신고 시
품명, 규격, 수량, 단가, 거래조건, 원산지를 기재하며 도착국 세관의 과세가격 산정 근거이기도 합니다.
공식 안내 - 선하증권(B/L) 또는 항공화물운송장(AWB)
- 발급:
- 운송인 또는 포워더
- 시점:
- 적재 후 발행
대금결제와 매수인의 물품 인수에 사용되며 수출환급 증빙의 일부이기도 합니다.
공식 안내 - 수출허가증 또는 이중용도품목·기술 수출허가증
- 발급:
- 상무부와 그 위임 발급기관
- 시점:
- 통제 또는 허가증 관리 품목의 경우 신고 전
이중용도품목은 최종사용자와 최종용도 확인이 필요하며, 일부 품목에는 별도의 통제목록이 있습니다.
공식 안내 - 출경화물 검사검역 서류
- 발급:
- 해관
- 시점:
- 법정검사 목록 상품의 경우 신고 전 완료
표본 검사, 검역 처리와 관련 증서를 포함합니다.
공식 안내 - 원산지증서
- 발급:
- 해관 또는 중국국제무역촉진위원회(CCPIT)
- 시점:
- 매수인이 도착국에서 특혜세율을 신청할 때
RCEP·한중 FTA 원산지증서, 대만행 조기수확 목록 물품의 ECFA 원산지증명서, 일반 원산지증서(CO)를 포함합니다.
공식 안내 - 보관위임협의(報關委託協議)
- 발급:
- 수출기업과 보관기업
- 시점:
- 대리 신고 위임 전
양측의 신고 책임과 수권 범위를 명확히 합니다.
공식 안내 - 수출환급 신청 자료
- 발급:
- 수출기업
- 시점:
- 물품 수출 신고와 수금 후
증치세 전용계산서(增值稅專用發票) 또는 매입 증빙, 수출화물 보관단 정보, 수금 증빙을 포함합니다.
공식 안내 - 선복예약서 또는 선적지시서
- 발급:
- 운송인 또는 포워더
- 시점:
- 선복 예약 후 수령
물품이 해관 감관작업장소로 반입되어 적재되는 근거입니다.
공식 안내
대만 수입 서류
- 진구보단(進口報單, 수입신고서)
- 발급:
- 보관업자 또는 수입인이 관항무단일창구로 전송
- 시점:
- 운송수단 수입일의 다음 날부터 15일 이내
저가 특송화물은 간이신고서(X1~X3)로 대체할 수 있습니다. 수입규정 대상, 환급, 할당, 특별관세, 특종화물세가 걸린 물품은 일반 진구보단으로 신고해야 합니다.
공식 안내 - 소제단(小提單, D/O 화물인도지시서)
- 발급:
- 운송인 또는 포워더
- 시점:
- 물품 도착 후 교부
컨테이너 집산장이나 창고에서 물품을 인수할 때 사용합니다.
공식 안내 - 상업송장(商業發票)
- 발급:
- 수출자
- 시점:
- 신고 시
완세가격 산정의 주된 근거로 품명, 수량, 단가, 거래조건, 원산지가 기재되어야 합니다.
공식 안내 - 포장명세서(裝箱單)
- 발급:
- 수출자
- 시점:
- 신고 시
C3 물품검사 시 대조 자료로 사용됩니다.
공식 안내 - 선하증권(B/L) 또는 항공화물운송장(AWB)
- 발급:
- 운송인
- 시점:
- 선적 시 발행
적하목록과 대조되며 소제단 교부의 근거가 됩니다.
공식 안내 - 산지증명서(產地證明書)
- 발급:
- 수출국 발급기관
- 시점:
- 특혜세율 신청 시 또는 수입규정이 요구할 때
중국 본토에서 ECFA 조기수확 목록 물품을 들여오면서 특혜세율을 받으려면 ECFA 원산지증명서가 필요합니다.
공식 안내 - 수입허가증(輸入許可證)
- 발급:
- 경제부 국제무역서 또는 그 밖의 주무기관
- 시점:
- 품목분류표 「수입규정」 란에 해당 코드가 있을 때
코드가 없으면 대개 면증 수입이며, MW0·MP1 등은 대륙물품 수입관리와 관련됩니다.
공식 안내 - 위임서(委任書)
- 발급:
- 수입인(납세의무자)
- 시점:
- 보관업자 위임 전
보관업자가 신고, 납세, 물품 인수를 대행하는 근거입니다.
공식 안내 - 검사·검험 관련 서류
- 발급:
- 경제부 표준검험국(BSMI), 위생복리부 식품약물관리서(TFDA)
- 시점:
- 신고와 동시 또는 신고 전
검사대상 상품의 보험합격증명, 수입식품 검사신청, 화장품 제품등록과 제품정보파일(PIF).
공식 안내
6절차
- 화물정보 사전전송과 반입운송인이 적하목록을 전송하고, 양하된 물품은 컨테이너 집산장, 부두 또는 보세창고에 반입됩니다.
- 소제단 교부와 서류 준비운송인 또는 포워더에게서 소제단을 교부받고 송장, 포장명세서, 산지증명서, 필요한 수입허가증을 준비합니다.
- 진구보단 제출보관업자 또는 수입인이 관항무단일창구로 진구보단을 제출합니다. 신고기한은 운송수단 수입일의 다음 날부터 15일 이내입니다.
- 통관구분 배정C1(면심면험), C2(서류심사), C3(물품검사, 인공검사 C3M과 기기검사 C3X) 중 하나로 배정됩니다. 검사대상 상품은 주무기관의 결과가 나와야 진행됩니다.
- 세액 납부관세, 영업세, 해당하는 화물세, 추광무역서비스비를 납부합니다. 온라인 납부가 가능하며 규정에 따라 선방후세(先放後稅)를 신청할 수도 있습니다.
- 방행과 인수방행통지(放行通知)를 받으면 집산장에서 물품을 인수합니다. 이후 정정, 환급, 사후심사 절차가 별도로 있습니다.
- 적하목록과 반입항공사가 적하목록을 전송하고 물품이 항공화물 집산장에 반입됩니다.
- 서류 준비와 보단 제출서류를 준비해 단일창구로 진구보단을 제출합니다. 15일 신고기한이 동일하게 적용됩니다.
- 통관구분과 검사C1·C2·C3로 분류되며, BSMI 또는 TFDA 관리 품목은 보험·검사 절차를 마쳐야 합니다.
- 납부관세, 영업세와 관련 규비를 납부합니다.
- 방행과 인수항공화물 집산장에서 물품을 인수합니다.
- 특송화물 구분완세가격에 따라 X1(수입 특송서류), X2(NT$2,000 이하 저가 면세), X3(NT$2,001~50,000 저가 과세), X4(NT$50,000 초과 고가)로 나뉩니다.
- 간이신고 또는 일반보단X1~X3은 간이신고서로 신고할 수 있습니다. X4와 수입규정·환급·할당·특별관세·특종화물세가 걸린 물품은 일반 진구보단으로 신고해야 합니다.
- 면세와 빈번수입 판단완세가격 NT$2,000 이하는 면세이나, 같은 납세의무자가 반년도 내 6회를 초과하면 빈번수입자로 분류되어 이후 면세가 적용되지 않습니다. 담배·주류·관세할당 농산물은 대상이 아닙니다.
- 납부과세 대상이면 특송업체가 대납 후 수취인에게 청구하거나 수취인이 직접 납부합니다.
- 검사대상 상품해외 온라인 구매한 전기기기 등 검사대상 상품도 보험 또는 면험 절차를 거쳐야 하며, 위반 시 방행되지 않고 처벌 대상이 될 수 있습니다.
- 입국 신고여행자가 과세 또는 신고 대상 물품을 휴대하면 홍색 통로를 이용하고 신고서를 작성합니다.
- 면세한도성인 여행자의 자가사용 휴대품은 완세가격 합계 NT$20,000 이하까지 면세이며, 주류와 담배는 별도의 수량 제한이 있습니다.
- 상용물품자가사용이 아닌 상용물품은 휴대 반입이라도 일반 수입절차에 따라 신고해야 하고, 수입규정과 검사요건도 충족해야 합니다.
- 납부면세한도를 초과하는 부분은 입국 시 세관이 과세가격을 산정해 현장에서 납부합니다.
중국 수출측 절차 보기
- 자격과 사전 조회해관 수발화인 등록과 수출환급 관련 등록을 마치고, 상품코드의 감관조건과 수출환급률을 조회해 허가증이나 법정검사 필요 여부를 판단합니다.
- 선복 예약·물품 준비·증서 취득선복을 예약해 선적지시서를 받고 포장과 화인을 완료하며, 수출허가증, 이중용도품목 허가, 출경 검사검역을 처리합니다.
- 신고적재 전에 단일창구로 수출화물 보관단을 제출합니다. 직접 신고 또는 보관기업 위임이 모두 가능합니다.
- 검사와 검사검역해관 검사에 응하고, 법정검사 상품이면 검사검역 절차를 완료합니다.
- 방행과 출항방행 후 선적해 출항하고 선하증권과 보관단 결관 정보를 확보합니다.
- 수금과 환급수금을 완료하고 규정에 따라 수출환급을 신청합니다. 서류와 신고 정보가 서로 일치해야 합니다.
7난이도
점수: 0.87
공개 데이터에서 계산한 신호이며, 자문이 아닙니다.
이렇게 판단한 이유
- regime[TFDA] 藥事法 — 藥商許可執照 + 藥品許可證 — 의약품은 藥商(수입) 허가 + 품목별 藥品許可證 필요. 개인 자가사용도 수량 제한.fda.gov.tw2026-09-07
- requirement도착국 수입요건 6건 확인: For importation of controlled drugs (including narcotics dru, (1) Importation of medicines for human use is governed by th, Importation of Chinese medicines (with the content of the foportal.sw.nat.gov.tw2026-09-07
- ambiguity품목분류가 갈릴 여지가 큼 — TW 결정례 17건 · 하위 세번 2종으로 분산web.customs.gov.tw2026-09-07
구성 요소
| 수입요건 | 0.89 | For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an ap portal.sw.nat.gov.tw(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of co portal.sw.nat.gov.twImportation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the dru portal.sw.nat.gov.tw |
|---|---|---|
| 분류 모호성 | 0.56 | TW 결정례 17건 · 하위 세번 2종으로 분산 web.customs.gov.twUS CROSS 1057건 중 복수 세번 결정 비율 21% · 같은 사건에서 함께 검토된 다른 HS6 66개 rulings.cbp.gov |
| 규제 제도 | 1.00 | 藥事法 — 藥商許可執照 + 藥品許可證 fda.gov.tw |
기준일: 2026-09-07
8사례
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)결정 세번: 30049099904결정일: 2021
- 其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶결정 세번: 30049069009결정일: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)결정 세번: 30049099904결정일: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者貽貝粘蛋白創面修復敷料 型號、規格:0.5mg/mL×0.2mL、0.5mg/mL×0.5mL、0.5mg/mL×1mL、0.5mg/mL×3mL、0.5mg/mL×5mL 0.5mg/mL×10mL、0.5mg/mL×15mL、0.5mg/mL×20mL、1.5mg/mL×0.2mL、1.5mg/mL×0.5mL 1.5mg/mL×3mL、……、1.5mg/mL×20mL等(詳附件)결정 세번: 30049099904결정일: 2018
- 其他中藥製劑云南彝葯排毒眼罩결정 세번: 30049069009결정일: 2018
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲筆(未滅菌) EXCILOR Nail Pen(non-sterile)결정 세번: 30049099904결정일: 2017
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液(未滅菌) EXCILOR Nail Solution(non-sterile)결정 세번: 30049099904결정일: 2017
- 其他中藥製劑黃金紅蔘精/液體(茶)食品/Net wt. 250g/真空玻璃瓶결정 세번: 30049069009결정일: 2017
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者品名:通用名:骨修復材料 商標名:骨優導 / 型號規格:1mg rhBMP-2/Bottle결정 세번: 30049099904결정일: 2017
- 其他中藥製劑韓國護肝寶 HD-1 Premium결정 세번: 30049069009결정일: 2017
- 其他中藥製劑晋山之韵/台灣商品名:沛之臨 益甘飲결정 세번: 30049069009결정일: 2017
- 其他中藥製劑慶珍丸결정 세번: 30049069009결정일: 2016
- 其他中藥製劑紅蔘鹿茸元氣精결정 세번: 30049069009결정일: 2016
- 其他中藥製劑五加皮精결정 세번: 30049069009결정일: 2016
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者ESOXX ONE결정 세번: 30049099904결정일: 2016
다른 나라 결정례 보기 (30)
- KRㅇ 재우스오라쿠고에이취플라스타(살리실산); OLAKUKO - H;
- KRMedicaments; 재우스오라쿠고에이취플라스타(살리실산)
- KRPOSS
- KRS1
- KRBOSS
- KRMedicaments; DIABEX XR 500mg
- KRINVISIBLE MASK
- KRMedicaments, packings for retail sale
- KRMedicament; Mentho Pas Lotion
- KRMedicaments, anti-cancer preparation TEPADINA, Thiotepa
- KRMedicaments; 인애백년보건고; PR.CHNA
- KRMedicaments; FD; MEXICO
- KRMedicaments; Turbocaina; MEXICO
- KRMedicaments; Nutriband Slimline patch; U.S.A
- KRCollagen Preparation; COLTRIX CartiRegen
- USThe tariff classification of Pantoprazole Sodium Tablets in dosage form, from India
- USThe tariff classification of Tadalafil Tablets in dosage form, from India
- USThe tariff classification of Nintedanib Capsules in dosage form, from India
- USThe tariff classification of Brivaracetam Oral Solution in dosage form, from India
- USThe tariff classification of Colestipol Hydrochloride Tablets in dosage form, from Taiwan
출처: 대만 재정부 — 해외 온라인 구매와 빈번수입 유의사항 · 대만 관무서 — 수입물품 영업세 대징 방법 · 대만 관무서 — 수입물품에 부과되는 세금과 비용 · 대만 관무서 — 대륙물품 수입 허용 범위 · 대만 타이베이관 — 수입 특송화물 간이신고 유의사항 · 대만 재정부 법규시스템 — 항공 특송화물 간이신고 통관작업 규정 · 대만 국제무역서 — 대륙물품 수입 특별규정 조회 · 대만 식품약물관리서 — 화장품 제품등록 전용 페이지 · 중국국제무역단일창구 · 중국 해관총서 온라인 민원 — 기업 등록과 신고 안내 · 중국 해관총서 · 중국 상무부 · 중국 국가세무총국 — 수출환급 · 중국국제무역촉진위원회
이용자 유형: 개인·소상공인 — 유형에 따라 강조되는 항목이 달라집니다